Iran Red Crescent Med J
November 2016
Background: The recent investigations have rendered microRNAs (miRs) as a novel biomarker in cancer research. In fact, alteration in miR expression may be associated with tumor suppression, tumorigenesis, metastasis, and poor prognosis in human breast cancer (BC).
Objectives: The aim of this clinical experimental study was to measure the miR-328 expression level in breast cancer tissues, at first.